首页> 美国卫生研究院文献>Clinical Pediatric Endocrinology >A Case with Hyperthyroidism Who Had Been Treated with Thyroid Hormone Becauseof Congenital Hypothyroidism
【2h】

A Case with Hyperthyroidism Who Had Been Treated with Thyroid Hormone Becauseof Congenital Hypothyroidism

机译:甲亢治疗甲状腺机能亢进一例先天性甲状腺功能减退症

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

We encountered a case with hyperthyroidism at the age of 14 who had been diagnosed with congenital hypothyroidism (CH) and had received thyroid hormone replacement therapy. At the age of 16 d, the patient was referred to our hospital because of positive results at neonatal screening for CH. Serum level of TSH was 91.0 μU/ml and serum level of T4 was 6.9 μg/dl. The patient was diagnosed as having hypothyroidism, and hormone replacement therapy was started. Thereafter the dosage of thyroid hormone was adjusted and increased gradually as he grew to a maximum dose of 110 μg/day at the age of 11. Until the age of 13, the patient’s serum levels of TSH were within the normal range; then, at the age of 13 yr and 4 mo, his serum level of TSH dropped to a level below the detectable range. The dosage of administered thyroid hormone was tapered off and eventually eliminated at the age of 14. A thyroid scan and a radioactive iodine uptake test demonstrated a diffuse goiter with homogeneous uptake of radioactive iodine; the uptake rate was 60% at 24 h, and the serum level of TSH receptor antibody (TRAb) was 62.5% at that time. Administration of an antithyroid drug was started after confirmation that our patient had developed hyperthyroidism. There have been no case reports similar to our case.
机译:我们遇到了一名14岁的甲亢患者,该患者被诊断患有先天性甲状腺功能减退症(CH),并接受了甲状腺激素替代治疗。由于新生儿CH筛查的阳性结果,该患者在16 d时被转诊到我们医院。 TSH的血清水平为91.0μU/ ml,T4的血清水平为6.9μg/ dl。患者被诊断患有甲状腺功能减退症,并开始了激素替代治疗。此后,调整甲状腺激素的剂量,并在11岁时逐渐增加至最大剂量110微克/天,直到13岁为止,患者的TSH血清水平均在正常范围内。然后,在13岁零4个月时,他的TSH血清水平降至低于可检测范围的水平。甲状腺激素的剂量逐渐减少,并最终在14岁时被淘汰。甲状腺扫描和放射性碘摄取测试显示甲状腺肿大且放射性碘摄取均匀。 24h摄取率为60%,TSH受体抗体(TRAb)当时的血清水平为62.5%。在确认我们的患者发展为甲状腺功能亢进后,开始给予抗甲状腺药物治疗。没有类似我们的案例的案例报告。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号